Radiologia Brasileira - Publicação Científica Oficial do Colégio Brasileiro de Radiologia

AMB - Associação Médica Brasileira CNA - Comissão Nacional de Acreditação
Idioma/Language: Português Inglês

Vol. 50 nº 6 - Nov. / Dec.  of 2017

LETTERS TO THE EDITOR
Print 

Page(s) 414 to 415

Giant cell tumor of the frontal sinus: a typical finding in an unlikely location

Autho(rs): Beatriz Morais e Rodrigues Cunha1; Marcelo Fontalvo Martin1; João Maurício Canavezi Indiani1; Marcelo Souto Nacif2

PDF English

PDF Português      

Texto em Português English Text

Dear Editor,

A 32-year-old female patient was admitted to the emergency room complaining of a knot on her forehead that had appeared 24 hours earlier. The patient underwent computed tomography (CT) of the skull, with and without intravenous administration of iodinated contrast medium. The CT scans revealed a dense, spontaneous, expansile extra-axial formation with its epicenter in the right frontal sinus, featuring an evident air-fluid level and well-defined borders (Figure 1A). On T2-weighted magnetic resonance imaging (MRI) sequences, the lesion also showed an air-fluid level (Figure 1B). A contrast-enhanced axial MRI scan showed peripheral enhancement (Figure 1C). The patient underwent surgery for complete resection of the lesion. The pathological examination demonstrated tumor-free margins, and immunohistochemistry showed that the lesion was characteristic of a giant cell tumor (GCT) of bone (Figure 1D).



Figure 1. A: Axial CT of the skull, after intravenous administration of contrast material, showing a dense, spontaneous, expansile extra-axial formation, measuring 3.1 × 2.5 × 2.9 cm, with its epicenter in the right frontal sinus, featuring bone destruction, an evident air-fluid level, and well-defined borders. B: T2-weighted axial MRI slice that best identified the predominantly cystic lesion with an air-fluid level due to the blood content, responsible for the rapid expansion of the tumor. C: Contrast-enhanced axial MRI slice showing marked peripheral enhancement. D: Histological section stained with hematoxylin and eosin, demonstrating spindle cell morphology, in a fascicular pattern, surrounding numerous large multinucleated osteoclasts.



GCT is one of the most common primary bone tumors, accounting for approximately 10% of all bone tumors and 25% of all benign bone tumors(1). It mainly affects individuals 20–40 years of age and has an insidious onset, presenting with pain and a local increase in volume(1). It is usually located in the epiphyses or metaphyses of the long bones, most commonly in the knees (distal femur or proximal tibia). Although it affects less than 1% of all bone sites within the skull (mainly the temporal and sphenoid bones), GCT tends to be more aggressive when it occurs at such sites(2–4).

Based on the classical radiographic aspects, GCT of bone can be defined as a lytic, expansile lesion, resulting in thinning or erosion of the cortical bone(5). CT is the best method to evaluate bone destruction and to identify pathological fractures. MRI can reveal soft tissue invasion and cystic areas (secondary aneurysmal hemorrhages or cysts)(6,7). The definitive diagnosis is made through the identification of giant cells in the histological analysis.

We believe that radiological symptom assessment is of great importance for the diagnosis of bone diseases, because some lesions allow a specific etiological diagnosis, whereas others must be treated on the basis of the description of the findings alone. In the present case, the radiological findings were quite typical. However, the extremely atypical location made it difficult to establish a specific diagnosis. There have been few reported cases of GCT of the skull; hence the relevance of this case.

In the case presented here, CT and MRI were both of extreme importance in the surgical planning and in the postoperative follow-up. The prognosis was favorable, and the patient progressed well in the postoperative period, without the need for radiotherapy. At this writing, she has been followed for approximately two years, without complaints or signs of local recurrence.


REFERENCES

1. Catalan J, Fonte AC, Lusa JRB, et al. Tumor de células gigantes ósseo: aspectos clínicos e radiográficos de 115 casos. Radiol Bras. 2006;39:119–22.

2. Martínez DF, Casasco JP, Bonis C, et al. Tumor de células gigantes de base de crâneo: reporte de 2 casos y revisión de la bibliografía. Rev Argent Neuroc. 2007;21:117–9.

3. Novaes V, Pinaud M, Paranhos JL, et al. Tumores de células gigantes do esfenoide: relato de 3 casos e revisão da literatura. Arq Neuropsiquiatr. 1977;35:57–67.

4. Cardona YG, González MBR. Presentación de un paciente con tumor óseo de células gigantes. Correo Científico Médico. 2013;17:518–22.

5. Camargo OP, Croci AT, Oliveira CRGCM, et al. Tumor de células gigantes – evolução histórica do seu diagnóstico e tratamento junto ao Instituto de Ortopedia e Traumatologia da FMUSP. Acta Ortop Bras. 2001;9:46–52.

6. Matushita JP, Matushita JS, Simões LAM, et al. Giant cell tumor of the frontal sinus: case report. Radiol Bras. 2013;46:255–8.

7. Baptista PPR, Próspero JD, Yonamine ES. Tumor de células gigantes. Rev Bras Ortop. 2001;36:239–44.










1. Unidade de Radiologia Clínica (URC), São José dos Campos, SP, Brazil
2. Universidade Federal Fluminense (UFF), Niterói, RJ, Brazil

Mailing address:
Dra. Beatriz Morais e Rodrigues Cunha. Unidade de Radiologia Clínica – Radiologia
Rua Teopompo de Vasconcelos, 245, Vila Adyana
São José dos Campos, SP, Brazil, 12243-830
E-mail: cunhabi@hotmail.com
 
RB RB RB
GN1© Copyright 2024 - All rights reserved to Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
Av. Paulista, 37 - 7° andar - Conj. 71 - CEP 01311-902 - São Paulo - SP - Brazil - Phone: (11) 3372-4544 - Fax: (11) 3372-4554